SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : OSI Pharmaceuticals (OSIP) - formerly Oncogene -- Ignore unavailable to you. Want to Upgrade?


To: Joe Wesley who wrote (302)11/7/2005 4:47:50 PM
From: tuck  Read Replies (1) | Respond to of 447
 
Lucentis ANCHOR data looks pretty good, though we didn't get specific numbers regarding the patients gain of 3 lines or more of vision. Things do not look good for Macugen at all.

Message 21863891

Surprisingly, to me, OSI is off only a tenth after hours.

Cheers, Tuck